Total Payments
$22,069
2024 Payments
$2,857
Companies
75
Transactions
1,508
Medicare Patients
9,537
Medicare Billing
$560,496
Payment Breakdown by Category
Food & Beverage$22,028 (99.8%)
Education$40.62 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,028 | 1,503 | 99.8% |
| Education | $40.62 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,839 | 145 | $0 (2024) |
| Novo Nordisk Inc | $1,668 | 109 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,416 | 132 | $0 (2024) |
| PFIZER INC. | $1,375 | 107 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,354 | 89 | $0 (2024) |
| Amgen Inc. | $1,344 | 72 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,245 | 61 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,071 | 87 | $0 (2024) |
| Lilly USA, LLC | $986.31 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $942.89 | 71 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,857 | 166 | ABBVIE INC. ($366.17) |
| 2023 | $3,238 | 216 | ABBVIE INC. ($424.29) |
| 2022 | $2,616 | 187 | ABBVIE INC. ($367.59) |
| 2021 | $2,466 | 174 | AbbVie Inc. ($389.71) |
| 2020 | $1,505 | 96 | Amgen Inc. ($137.57) |
| 2019 | $2,960 | 204 | Novartis Pharmaceuticals Corporation ($297.31) |
| 2018 | $3,214 | 224 | Novartis Pharmaceuticals Corporation ($321.15) |
| 2017 | $3,213 | 241 | Amgen Inc. ($403.07) |
All Payment Transactions
1,508 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VACCINES | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Biological | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: VACCINE | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Biological | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,282 | 3,016 | $502,348 | $114,927 |
| 2022 | 20 | 2,238 | 3,030 | $504,258 | $118,786 |
| 2021 | 19 | 2,540 | 3,382 | $519,717 | $126,168 |
| 2020 | 20 | 2,477 | 3,201 | $533,758 | $200,615 |
Total Patients
9,537
Total Services
12,629
Medicare Billing
$560,496
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 919 | $192,071 | $24,047 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 291 | $46,851 | $17,213 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 403 | 403 | $90,675 | $16,489 | 18.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $29,624 | $15,798 | 53.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 82 | $36,818 | $10,069 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 140 | $19,880 | $5,320 | 26.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 65 | 65 | $5,330 | $4,928 | 92.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 339 | 349 | $13,611 | $4,406 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 366 | 372 | $19,344 | $3,073 | 15.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $6,061 | $2,695 | 44.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 20 | 20 | $2,300 | $2,254 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 76 | 76 | $3,116 | $2,180 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 69 | $2,829 | $1,979 | 70.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 34 | 45 | $15,525 | $1,789 | 11.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 47 | $13,207 | $1,166 | 8.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 18 | $2,898 | $1,090 | 37.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 33 | $1,716 | $315.24 | 18.4% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 12 | $492.00 | $116.88 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 484 | 828 | $173,052 | $23,203 | 13.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 395 | $63,595 | $21,403 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 357 | 357 | $80,325 | $14,972 | 18.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 67 | $30,083 | $9,811 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 212 | $30,104 | $8,406 | 27.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 83 | $19,173 | $6,440 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 92 | 92 | $7,360 | $6,306 | 85.7% |
About Dr. Joe Reese, M.D
Dr. Joe Reese, M.D is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730152265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joe Reese, M.D has received a total of $22,069 in payments from pharmaceutical and medical device companies, with $2,857 received in 2024. These payments were reported across 1,508 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($22,028).
As a Medicare-enrolled provider, Reese has provided services to 9,537 Medicare beneficiaries, totaling 12,629 services with total Medicare billing of $560,496. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tulsa, OK
- Active Since 02/07/2006
- Last Updated 04/20/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730152265
Products in Payments
- ENTRESTO (Drug) $926.69
- XARELTO (Drug) $838.37
- JARDIANCE (Drug) $807.75
- UBRELVY (Drug) $743.21
- TRELEGY ELLIPTA (Drug) $675.15
- JANUVIA (Drug) $631.87
- ELIQUIS (Drug) $618.68
- FARXIGA (Drug) $601.08
- Prolia (Biological) $477.26
- XIFAXAN (Drug) $407.07
- LINZESS (Drug) $356.22
- VRAYLAR (Drug) $332.03
- Vascepa (Drug) $324.85
- MOUNJARO (Drug) $317.97
- Kerendia (Drug) $305.66
- BELSOMRA (Drug) $305.48
- EVENITY (Biological) $297.36
- PREVNAR 20 (Biological) $294.81
- CHANTIX (Drug) $294.76
- TRULICITY (Drug) $286.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Jesse Richards, D.o, D.O
Internal Medicine — Payments: $147,415
Internal Medicine $147,415
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876